Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
21.42
+0.05 (0.23%)
Mar 13, 2026, 4:00 PM EDT - Market closed

Revenue by Geography

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18
United States Revenue
358.95M365.00M365.05M
United States Revenue Growth
-1.66%-0.01%3.88%
China Revenue
61.39M58.35M58.24M
China Revenue Growth
5.22%0.18%11.72%
United Kingdom Revenue
37.58M35.39M27.20M
United Kingdom Revenue Growth
6.19%30.08%2.04%
Rest of Europe Revenue
109.55M107.37M95.15M
Rest of Europe Revenue Growth
2.03%12.84%9.14%
Asia Pacific/ Other Revenue
27.48M27.71M27.79M
Asia Pacific/ Other Revenue Growth
-0.83%-0.29%-18.50%
Revenue (Total)
594.95M593.82M573.45M
Revenue (Total) Growth
0.19%3.55%3.98%

Revenue Breakdown

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18
Sample Management Solutions Revenue
324.80M324.59M318.90M
Sample Management Solutions Revenue Growth
0.07%1.79%5.18%
Multiomics Revenue
270.15M269.23M254.55M
Multiomics Revenue Growth
0.34%5.77%2.52%
Revenue (Total)
594.95M593.82M573.45M
Revenue (Total) Growth
0.19%3.55%3.98%

Revenue Breakdown 2

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18
Multiomics Revenue
270.15M269.23M254.55M
Multiomics Revenue Growth
0.34%5.77%2.52%
Core Products Revenue
195.54M197.63M196.50M
Core Products Revenue Growth
-1.06%0.57%2.31%
Sample Repository Solutions Revenue
129.26M126.96M122.39M
Sample Repository Solutions Revenue Growth
1.81%3.73%10.14%
Revenue (Total)
594.95M593.82M573.45M
Revenue (Total) Growth
0.19%3.55%3.98%

Adjusted EBIT

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18
Sample Management Solutions Adjusted Operating Income
29.55M27.55M11.11M
Sample Management Solutions Adjusted Operating Income Growth
7.27%148.06%-
Multiomics Adjusted Operating Income
-13.75M-11.94M-7.73M
Operating Income (Total)
-22.73M-26.84M-51.28M

Key Performance Indicators

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18
Organic Revenue Growth
3.00%-2.00%
Updated Feb 4, 2026. Data Source: Fiscal.ai.